Company / Assets per Share
Celldex Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$8.76
FY2025
5-year range
$7.47 / $11.94
FY2021-FY2025
Trend
-26.6%
vs FY2024
Sector context
#132 of 159
Health Care
What the data says
Celldex Therapeutics, Inc.'s assets per share of $8.76 is lower than 83% of companies in the Health Care sector (FY2025). Assets per Share has fluctuated over the past 10 years, ranging from $2.62 in FY2017 to $16.87 in FY2018.
Based on SEC 10-K filings.
8.76 in FY2025 with a 5-year CAGR of +8.0%.
Improved from $8.33 to $8.76 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 159This company $8.76 Sector average $117.35
▼
-92.5% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 26.6% year-over-year.
- Ranks #132 out of 159 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.76 | -26.6% |
| FY2024 | $11.94 | +43.3% |
| FY2023 | $8.33 | +11.5% |
| FY2022 | $7.47 | -21.5% |
| FY2021 | $9.52 | +59.8% |
| FY2020 | $5.95 | -17.8% |
| FY2019 | $7.24 | -57.1% |
| FY2018 | $16.87 | +544.2% |
| FY2017 | $2.62 | -17.7% |
| FY2016 | $3.18 | -7.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026